Jon Flynn provides economic and statistical analysis in connection with antitrust matters regarding market power and damages issues. He has extensive experience in all aspects of litigation support including data management and analysis, damages, document review, exhibit and report creation. His experience spans over a decade in analyzing, developing, and managing large, complex databases. He has constructed models to calculate damages and establish liability in monopolization and fraud cases.
Mr. Flynn has worked on a broad range of litigation matters including contractual disputes, fraud, and competition economics. His work spans numerous industries including computer software and hardware, consumer products, energy, financial markets, health care, insurance, medical products, and pharmaceuticals.
Mr. Flynn is a member of the pharmaceutical group at Econ One and has worked on a variety of cases involving exclusionary conduct in the pharmaceutical industry. He is versed in the economics of the different life-cycle strategies of branded pharmaceutical companies such as line extensions, reverse payment settlements, and cannibalizing old formulations. Additionally, he has worked on several projects involving overpayments for Medicaid reimbursements.
M.A. in Economics with emphasis in Econometric Forecasting and Finance, University of California, Santa Barbara
B.A. in Mathematics-Economics, University of California, Santa Barbara
Econ One, June 2003 – Present